This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.

M-tron Industries, Inc.
3/26/2026
hello and thank you for standing by my name is bella and i will be your conference operator today at this time i would like to welcome everyone to amtron earnings call for q4 2025 all lines have been placed on mute to prevent any background noise after the speaker's remarks there will be a question and answer session we do request for today's session that you please limit to one question only and one follow-up if you would like to ask a question during this time simply press star and the number one on your telephone keypad. To withdraw your question, press star one again. I would now like to turn the conference over to Linda Biles, Executive Vice President of Finance. You may begin.
Good morning, everyone. Thank you for joining our Emtron Q4 2025 and fiscal year 2025 earnings call. Please note that this call will be recorded and we will make the recording available on our website www.mtron.com shortly after the call. Tuesday afternoon, we released our earnings for the fourth fiscal quarter of 2025 and annual fiscal year 2025. Before getting underway, we are required to advise you that the following discussion should be taken in conjunction with our most recent financial statements and notes as contained within our 2025 10-K, which was filed today on March 26 with the SEC. This discussion may contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities and Exchange Act of 1934. These forward-looking statements contain known and unknown risks and uncertainties, which are detailed in our filings with the SEC. Although the company believes that the forward-looking statements are based upon reasonable assumptions regarding its business and future market conditions, There are no assurances that the company actual results will not differ materially from any result expressed or implied by the company's forward-looking statements. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events, or otherwise. Readers are cautioned that any forward-looking statements are not guarantees of future performance. With that, I will now turn the call over to our CEO, Cameron Fore.
Thank you, Linda. Good morning, everyone. Thank you for joining our fourth quarter and annual FY25 earnings call and your interest in the company. We are pleased to discuss our strong finished 2025 fiscal year and our outlook going forward. Emdron designs and manufactures highly engineered RF solutions, including electronic components and sub-assemblies used to control the frequency and timing of signals and electronic circuits. We're a global company with three manufacturing sites in the United States and India. The company's primary markets include aerospace and defense, commercial avionics, space, and industrial markets. We're pleased to report that the company continued to perform well, with continued strength in Amtron sales and good financial performance for Q4 FY 2025. Our revenues continue to be driven by defense-related orders and strong improvement in the commercial aircraft or what we call the avionics sector. Booking's growth was particularly strong with a 62% increase in backlog over the 2024 year-end figure. With improved operating leverage, We have been able to continue to make strategic investments in research and development and continued our efforts to increase the market profile of the company and the request for quotes that that visibility is generating. We also continue to make investments in our production facilities and made several equipment upgrades in addition to our production lines as we prepare for increased demand. The past quarter has been an extremely active one for the defense sector. With the recent military action in Venezuela and Iran, it's easy to get distracted from some of the important fundamental industry news. The FY2026 defense budget was approved for FY26 through HR 7148 signed by President Trump in early 2026. With the White House and Department of War have also voiced a desire to increase military procurement. to the $1.5 trillion level from the current annual $968 billion budget from 2026. In February, both Lockheed Martin and Raytheon announced that they had signed seven-year production agreements with the Department of War to dramatically increase production over time for several important missile systems that each produce. Amtron is a significant vendor to both of these companies for many precision-guided munition programs. Over the past several years, this has been one of the most significant growth areas for Imtron. In fact, we believe that Imtron is one of the highest levels of missile content in its revenue among publicly listed U.S.-based companies. After many months of discussion and planning around how we could significantly increase production levels if required, we are now being asked to bid on components to several of these contracts. Provided that we do win significant design slots, we would anticipate not seeing an additional increase to our production volumes over what we received recently in December and January, so late 2027 or 28. Overall, we believe that we are well positioned to continue to perform well with a significant upside potential given Department of War's actions and the recent conflicts in Iran, which does not appear to have been factored into the current demand cycle. We reported the following Q4 2025 results. Total revenues for the fourth quarter were 14.2 million, an 11.2% increase over the same period last year. Revenue increase in the period was primarily due to strong defense program product as well as avionics shipments. Gross margins for the fourth quarter of 2025 were 46.9 as compared to 47.2 in Q4 2024. The gross margins were impacted by a level of tariffs not experienced in 24 and the product mix. Net income per diluted share was 99 cents for the three months ended December 31st, 2025, as compared to 73 cents per share in the prior year's period. An adjusted EBITDA was 4.5 million for the three months ending December 31st, 25. or an increase of 46.8% over the 3.1 million adjusted EBITDA for Q4 of FY 2024. The increase was primarily driven by higher revenues, lower engineering, sales and administrative expense as a percent of revenue and was offset by the lower gross margins. Backlog at the end of the quarter was 76.4 million as compared to 47.2 million as of December 31, 2024. The 62% increase reflects the continued strategy and focus on securing large, long-duration program-centric business. During 2025, we secured several multi-year purchase orders for defense programs. In addition, the timing of these purchase orders can materially affect backlog. For the fiscal 2025 year, we reported the following results. Total revenues for the 2025 fiscal year were $54.4 million, an 11.2% increase over the same period last year. The revenue increase in the period primarily due to defense program product and solution shipments, as well as an increase in avionics shipments. Gross margins for 2025 were 44.4%, as compared to 46.2% gross margin in 2024. Gross margin was impacted by the higher tariff-related costs and a less favorable product mix compared to 2024, primarily around new product introductions. Net income was $8.4 million, or $2.62 per diluted share in 2025, as compared to $7.6 million, or $26.5 per share in 2024. The increase in the actual net income was driven to the increase in revenue, partially offset by the higher cost of sales. Adjusted EBITDA was 12.6 million in 2025, as compared to 11.1 million in 2024. The increase was primarily due to higher revenues, continued operating leverage, and a lower incentive compensation, partially offset by lower gross margins. Speaking of the lower compensation expense, In 2024, the company paid a cash bonus to employees and management for overachieving its annual plan. In 2025, management anticipated the company being able to achieve similar results against plan, but the results while reflecting solid operational execution in a challenging environment marked by tariffs and increased new product introductions did not achieve this result. As a result, the company reversed $860,000 and earlier accrued incentive compensation expense, which had a favorable 6% impact on the fourth quarter results. For comparison purposes, in fiscal year 2024, the cash bonus plan expense totaled $1.4 million, representing approximately 3% of revenue. For 2025, the board decided to grant stock compensation in lieu of cash to further align the long-term interest of employees and management with shareholders. The Board of Directors now intends to develop a more balanced incentive plan expected to incorporate several performance metrics designed to encourage, measure, and reward the long-term sustainable growth of the company's revenue and earnings. We had a lot of activity in Q4 2025 to strengthen the balance sheet. Imtron operations are at the performance level currently where it's starting to accumulate cash on the balance sheet. In fiscal year 2025, we added $10.7 million of cash through operations. In addition, in December 2025, we signed a new loan agreement with Fifth Third Bank, which provided the company the ability to borrow up to $20 million at a very competitive rate based on company leverage. Currently, we have no debt outstanding and haven't drawn upon this line. Lastly, at the end of the year, we closed the warrant offering that we launched in the spring of 2025. The offering was fully subscribed with 582,233 shares being issued at the end of December and early January. And net proceeds of 27 and a half million being raised for the company, increasing our flexibility to pursue acquisitions that align with our long-term strategy. At the end of the period, Emtron had 20.9 million of cash on the balance sheet with an additional 27.5 million being transferred early January 2026 to the company from our transfer agent as warrant proceeds. As we look forward into 2026, we continue to expand our defense program business, which makes up the vast majority of our airspace and defense revenue. Two of the areas where we expect strong growth in 26 and 27 are radar and electronic warfare. These are areas that we emphasize from a sales and engineering perspective several years ago. There's a broad redesign of many military fire control radars due to the change in warfare, incorporating a breadth of weapons ranging from hypersonic missiles to small and slow moving or even loitering drones. There's also a newer class of mid-range radar being developed and widely deployed for counter drone missions. We are active in this market as well and have seen demand increase over the recent periods. Control of the electromagnetic spectrum is more important than ever, as autonomous software-driven systems play a greater role on the battlefield. We also continue to expect strong growth throughout the year from commercial avionics shipments, as we serve key suppliers to both Boeing and Airbus. Our position in this market is quite strong, and our products are used in 15 to 17 different applications on every commercial airframe that Airbus and Boeing produce. With inventories largely depleted at the airframe manufacturers, orders for components and subsystems have picked up as the airframe manufacturers executed on their backlog projected to be strong through 2035. While our management team is focused on executing on our organic growth strategy, We are placing a greater emphasis on combining that with inorganic growth through partnership and acquisitions. In 2025, we formed three strategic partnerships with complementary product companies. We recently announced a rights offering to provide the team greater flexibility to execute against our acquisition strategy. The record date for these rights will be tomorrow, March 27, 2026. Shareholders of record who exercise their full basic subscription rights are eligible to participate in the oversubscription feature should there be unallocated shares from the offering. The offering is expected to launch early next week, and the rights are expected to expire on April 15, 2026. Five rights will be required to purchase one share of common stock. And the subscription price per share will be determined next week when we file our prospective supplement on Monday or Tuesday, March 30th or 31st. It's anticipated that the subscription price will be at a 10 to 12% discount to the trailing five-day volume-weighted average price per share. This offering is designed to support accretive acquisitions, the ability to perform carve outs or participate in carve outs, transactions to scale, the pursuit of strategic investments, and also to expand our internal capabilities to meet demand. I'd like to thank our loyal employees for supporting the company and its mission of serving the nation and its capability to defend freedom. EnTron plays a critical role in the defense of our nation by providing U.S. source highly engineered components for many U.S. and allied military programs. Strengthening the U.S. defense industrial base is more important than ever, And we thank our employees for their dedication to their jobs, their fellow employees, and our mission. We also want to thank our customers for their continued business and partnership. I want to mention that we will be holding an Investor Day in New York on May 12th, beginning at 12 p.m. at the New York Stock Exchange at 11 Wall Street. I hope you can attend that. Please check our investor relations calendar on our IR website, ir.intron.com. for announcements about this and other investor events. With that, operator, can you please open the lines and allow the first question?
You're reading a preview of the MPTI Q4 2025 earnings call.
Free account.